Investor Relations | AmpliPhi Biosciences Corporation

Company Overview

Ampliphi Biosciences Corp is a biotechnology company committed to the development and commercialization of innovative therapies for the prevention and treatment of diseases with significant unmet medical need. Ampliphi Biosciences is based in Seattle, Washington and has been public since May 1994 and its stock trades on the FINRA OTC Bulletin Board under the ticker symbol APHB.PK.

AmpliPhi in the News

New technique will speed up DNA extraction

Anna spent 16 weeks in quarantine to overcome a mutant form of TB: The common diseases mutating into killers
June 21, 2011 – MailOnline

Revived Interest in Bacteriophages
April 26, 2011 -- Current Biology, Volume 21, Issue 8, R267-R270

Recent News

More News >>


04/16/13	AmpliPhi Establishes Collaboration with Intrexon
02/04/13	AmpliPhi Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-resistant Biofilm-based Infections
11/13/12	Bacteriophage-based Anti-infective Companies AmpliPhi and Special Phage Services Complete Merger
09/10/12	AmpliPhi to Combine with Special Phage Services to Create World’s Leading Anti-Infective Company Focused on Bacteriophage-Based Therapies

Upcoming Events

More Events >>

There are currently no events scheduled.

Featured Report

2008 10-K

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

APHB (Common Stock)

$0.17

0.01 (6.25%) 17,700
05/23/13 3:41 p.m. ET

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Ampliphi Biosciences Corp posts new information to the site. Just enter your e-mail address and click Submit.

	Print Page
	E-mail Page
	RSS Feeds
	E-mail Alerts